ORASURE TECHNOLOGIES INCOSUREarnings & Financial Report

Nasdaq · pharmaceutical industry

OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test.

Revenue

$27.1M

Gross Profit

$11.8M

Operating Profit

$-16.1M

Net Profit

$-13.7M

Gross Margin

43.5%

Operating Margin

-59.4%

Net Margin

-50.6%

YoY Growth

-32.1%

EPS

$-0.19

Financial Flow

ORASURE TECHNOLOGIES INC Q3 2025 Financial Summary

ORASURE TECHNOLOGIES INC reported revenue of $27.1M for Q3 2025, with a net profit of $-13.7M (-50.6% margin). Cost of goods sold was $15.3M, operating expenses totaled $27.9M.

Key Financial Metrics

Total Revenue	$27.1M
Net Profit	$-13.7M
Gross Margin	43.5%
Operating Margin	-59.4%
Report Period	Q3 2025

ORASURE TECHNOLOGIES INC Annual Revenue by Year

ORASURE TECHNOLOGIES INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $185.8M).

Year	Annual Revenue
2024	$185.8M
2023	$405.5M
2022	$387.5M

Income Statement

	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Revenue	$75.9M	$54.1M	$54.3M	$39.9M	$37.4M	$29.9M	$31.2M	$27.1M
YoY Growth	-38.3%	-65.1%	-36.4%	-55.2%	-50.7%	-44.7%	-42.5%	-32.1%

Balance Sheet

	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Assets	$482.8M	$467.6M	$466.3M	$464.1M	$479.7M	$457.6M	$445.0M	$423.1M
Liabilities	$52.2M	$41.3M	$40.5M	$38.5M	$69.3M	$61.3M	$64.3M	$61.1M
Equity	$430.7M	$426.3M	$425.8M	$425.6M	$410.3M	$396.3M	$380.7M	$362.0M